Thus, although it is possible that sPLA2-IIA and sPLA2-X might participate in certain forms of skin pathology such as cancer, it is nonetheless likely that sPLA2-IIF is the primary sPLA2 acting in the epidermis of both mice and humans under physiological conditions. This evidence concerns the gene PLA2G10 and cancer.